KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Resmed (RMD) FCF Margin (2016 - 2025)

Historic FCF Margin for Resmed (RMD) over the last 17 years, with Q4 2025 value amounting to 21.87%.

  • Resmed's FCF Margin fell 5900.0% to 21.87% in Q4 2025 from the same period last year, while for Dec 2025 it was 33.19%, marking a year-over-year increase of 49400.0%. This contributed to the annual value of 32.29% for FY2025, which is 45000.0% up from last year.
  • Resmed's FCF Margin amounted to 21.87% in Q4 2025, which was down 5900.0% from 31.02% recorded in Q3 2025.
  • In the past 5 years, Resmed's FCF Margin registered a high of 43.19% during Q1 2025, and its lowest value of 10.29% during Q3 2021.
  • Its 5-year average for FCF Margin is 20.66%, with a median of 22.28% in 2024.
  • In the last 5 years, Resmed's FCF Margin tumbled by -276400bps in 2021 and then surged by 216000bps in 2023.
  • Resmed's FCF Margin (Quarter) stood at 21.17% in 2021, then plummeted by -54bps to 9.8% in 2022, then skyrocketed by 119bps to 21.46% in 2023, then grew by 5bps to 22.46% in 2024, then decreased by -3bps to 21.87% in 2025.
  • Its FCF Margin stands at 21.87% for Q4 2025, versus 31.02% for Q3 2025 and 37.7% for Q2 2025.